IHS Chemical Week

Regions :: Western Europe :: Netherlands

Johnson & Johnson Buys 18% Stake in Crucell

7:12 AM MDT | September 30, 2009 | Deepti Ramesh

Biopharmaceutical company Crucell (Leiden, Netherlands) says that Johnson & Johnson (J&J), through its affiliate JHC Nederland, has purchased about 18% of Crucell’s outstanding ordinary shares for a total purchase price of €302 million ($441 million). Crucell and J&J have also entered into a strategic collaboration for the discovery, development and commercialization of monoclonal antibodies and vaccines for the treatment and prevention of influenza and other infectious and non-infectious diseases, Crucell says. The companies have agreed to...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa